Synergism of polyene antibiotics with 5-fluorocytosine
- PMID: 338264
- DOI: 10.1159/000237753
Synergism of polyene antibiotics with 5-fluorocytosine
Abstract
The synergism of 5-FC with 4 polyene antibiotics, amphotericin B (amph. B), candicidin, trichomycin and nystatin were investigated in 3 in vitro models measuring the fungistatic and fungicidal activity as well as the development of resistant mutants. In these 3 models candicidin and trichomycin exerted a higher synergistic effect than amph. B or nystatin. In vivo (systemic treatment of septicemic candidiasis of the mouse) the combination of 5-FC with amph. B was, however, the most effective. Only with this combination a complete cure (culturally negative) was observed. For topical treatment of Candida vaginitis in rats, the combination of 5-FC with candicidin proved the most active. As far as the biochemical basis of synergism is concerned in Candida albicans in the presence of polyene antibiotics, the incorporation of fluorinated pyrimidines was increased and the reduction of uptake of histidine by 5-FC alone, significantly enhanced. These effects could not be observed in Cryptococcus neoformans. The release of amino acids, phosphate and potassium caused by polyenes was significantly more pronounced in cells pretreated with 5-FC. Thus, the interaction between 5-FC and the polyenes may, in fact be, mutual.
Similar articles
-
In vitro and in vivo antifungal activity of the combination methylpartricin-5-fluorocytosine.Chemioterapia. 1984 Apr;3(2):119-25. Chemioterapia. 1984. PMID: 6398120
-
Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi. 1982 May;15(2):106-12. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi. 1982. PMID: 7047097
-
Proceedings: Synergism between 5-fluorocytosine and polyene antibiotics.Pathol Microbiol (Basel). 1975;42(4):234-5. doi: 10.1159/000162761. Pathol Microbiol (Basel). 1975. PMID: 778764 No abstract available.
-
Anti-Candida drugs--the biochemical basis for their activity.Crit Rev Microbiol. 1987;15(1):57-72. doi: 10.3109/10408418709104448. Crit Rev Microbiol. 1987. PMID: 3319421 Review.
-
Immunomodulating activity of antifungal drugs.Ann N Y Acad Sci. 1993 Jun 23;685:447-57. doi: 10.1111/j.1749-6632.1993.tb35905.x. Ann N Y Acad Sci. 1993. PMID: 8363252 Review.
Cited by
-
Combination antifungal therapy for the treatment of invasive yeast and mold infections.Curr Infect Dis Rep. 2007 Nov;9(6):448-56. doi: 10.1007/s11908-007-0069-1. Curr Infect Dis Rep. 2007. PMID: 17999880
-
Treatment of systemic fungal infections: recent progress and current problems.Eur J Clin Microbiol Infect Dis. 1988 Aug;7(4):460-75. doi: 10.1007/BF01962595. Eur J Clin Microbiol Infect Dis. 1988. PMID: 2846299 Review.
-
Combination Antifungal Therapy: A Review of Current Data.J Clin Med Res. 2017 Jun;9(6):451-456. doi: 10.14740/jocmr2992w. Epub 2017 Apr 26. J Clin Med Res. 2017. PMID: 28496543 Free PMC article. Review.
-
Evaluation of vaginal antifungal formulations in vivo.Postgrad Med J. 1979 Sep;55(647):648-52. doi: 10.1136/pgmj.55.647.648. Postgrad Med J. 1979. PMID: 392480 Free PMC article.
-
Antifungal combination therapy: clinical potential.Drugs. 2005;65(11):1461-80. doi: 10.2165/00003495-200565110-00002. Drugs. 2005. PMID: 16033288 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials